CATALYST PHARMACEUTICALS, INC. (CPRX)
search
Earnings reactions
How CPRX moved on each past earnings report.
Up
Down
Earnings Impact
CATALYST PHARMACEUTICALS, INC. (CPRX) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
Historical Earnings Statistics
CATALYST PHARMACEUTICALS, INC. (CPRX) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
event
Earnings Count
0
Total earnings in dataset
trending_up
Avg Abs. Movement
±0.00%
Avg % price change on earnings
account_balance
View all 32 →
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
32
Funds holding
$1345837576
Total value held
Buying
22 added · 9 reduced
Blackrock, Inc.
$602160611
+2.05%
State Street Corp
$239718530
+11.13%
Jpmorgan Chase & Co
$99885374
+579.04%
Morgan Stanley
$86758074
+2.72%
Janus Henderson Group Plc
$49520437
NEW BUY
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 15-12G | 20260724 | open_in_new SEC.gov |
| 4 | 20260717 | open_in_new SEC.gov |
| 4 | 20260717 | open_in_new SEC.gov |
| 4 | 20260717 | open_in_new SEC.gov |
| 4 | 20260717 | open_in_new SEC.gov |
| 4 | 20260717 | open_in_new SEC.gov |
| 4 | 20260717 | open_in_new SEC.gov |
| 4 | 20260717 | open_in_new SEC.gov |
| 4 | 20260717 | open_in_new SEC.gov |
| 4 | 20260717 | open_in_new SEC.gov |